These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. Lada AT, Davis M, Kent C, Chapman J, Tomoda H, Omura S, Rudel LL. J Lipid Res; 2004 Feb 01; 45(2):378-86. PubMed ID: 14617738 [Abstract] [Full Text] [Related]
13. New verticilides, inhibitors of acyl-CoA:cholesterol acyltransferase, produced by Verticillium sp. FKI-2679. Ohshiro T, Matsuda D, Kazuhiro T, Uchida R, Nonaka K, Masuma R, Tomoda H. J Antibiot (Tokyo); 2012 May 01; 65(5):255-62. PubMed ID: 22415459 [Abstract] [Full Text] [Related]
14. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety. Obata R, Sunazuka T, Tian Z, Tomoda H, Harigaya Y, Omura S. J Antibiot (Tokyo); 1997 Mar 01; 50(3):229-36. PubMed ID: 9127194 [Abstract] [Full Text] [Related]
15. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2. An S, Cho KH, Lee WS, Lee JO, Paik YK, Jeong TS. FEBS Lett; 2006 May 15; 580(11):2741-9. PubMed ID: 16647063 [Abstract] [Full Text] [Related]
16. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Omura S, Willingham MC, Rudel LL. Circulation; 2004 Oct 05; 110(14):2017-23. PubMed ID: 15451793 [Abstract] [Full Text] [Related]
17. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2. Ohtawa M, Yamazaki H, Matsuda D, Ohshiro T, Rudel LL, Ōmura S, Tomoda H, Nagamitsu T. Bioorg Med Chem Lett; 2013 May 01; 23(9):2659-62. PubMed ID: 23535327 [Abstract] [Full Text] [Related]
18. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs. Obata R, Sunazuka T, Kato Y, Tomoda H, Harigaya Y, Omura S. J Antibiot (Tokyo); 1996 Nov 01; 49(11):1149-56. PubMed ID: 8982344 [Abstract] [Full Text] [Related]
19. Design and Synthesis of A-Ring Simplified Pyripyropene A Analogues as Potent and Selective Synthetic SOAT2 Inhibitors. Ohtawa M, Arima S, Ichida N, Terayama T, Ohno H, Yamazaki T, Ohshiro T, Sato N, Omura S, Tomoda H, Nagamitsu T. ChemMedChem; 2018 Mar 06; 13(5):411-421. PubMed ID: 29323466 [Abstract] [Full Text] [Related]
20. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe. Kitayama K, Tanimoto T, Koga T, Terasaka N, Fujioka T, Inaba T. Eur J Pharmacol; 2006 Jul 01; 540(1-3):121-30. PubMed ID: 16730694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]